Literature DB >> 31171767

Correction: GWAS on family history of Alzheimer's disease.

Riccardo E Marioni1,2, Sarah E Harris3,4, Qian Zhang5, Allan F McRae5, Saskia P Hagenaars4,6, W David Hill4,7, Gail Davies4, Craig W Ritchie8, Catharine R Gale4,7,9, John M Starr4,10, Alison M Goate11, David J Porteous3,4, Jian Yang5,12, Kathryn L Evans3, Ian J Deary4,7, Naomi R Wray5,12, Peter M Visscher4,5,12.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2019        PMID: 31171767      PMCID: PMC6554304          DOI: 10.1038/s41398-019-0498-2

Source DB:  PubMed          Journal:  Transl Psychiatry        ISSN: 2158-3188            Impact factor:   6.222


Correction to: Translational Psychiatry 10.1038/s41398-018-0150-6 published online 18 May 2018 In the original Article, GWAS analysis of the UK Biobank data was based on standardised SNP dosages (standardised by their standard deviation) as opposed to raw SNP dosages. The standard error-weighted meta-analysis of the UK Biobank data with the IGAP findings was therefore incorrect. The meta-analysis has been re-run as previously specified (the key findings remain although four new genome-wide significant loci have been identified). There have also been updates to the Supplementary Tables and Fig. 1.
Fig. 1

  3 in total

Review 1.  The role of innate immunity in Alzheimer's disease.

Authors:  Hannah E Ennerfelt; John R Lukens
Journal:  Immunol Rev       Date:  2020-06-26       Impact factor: 12.988

Review 2.  Omics in Neurodegenerative Disease: Hope or Hype?

Authors:  Maria E Diaz-Ortiz; Alice S Chen-Plotkin
Journal:  Trends Genet       Date:  2020-01-10       Impact factor: 11.639

3.  TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.

Authors:  Zheng Zhu; Yang Yang; Zhenxu Xiao; Qianhua Zhao; Wanqing Wu; Xiaoniu Liang; Jianfeng Luo; Yang Cao; Minhua Shao; Qihao Guo; Ding Ding
Journal:  Aging Clin Exp Res       Date:  2020-07-28       Impact factor: 3.636

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.